S
IOVA icon

SignatureFD’s Iovance Biotherapeutics IOVA Stock Holding History

SignatureFD’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88K Hold
1,172
– – ﹤0.01% 2870
2026
Q1 		$4.11K Buy
1,172
+388
+49% +$1.24K ﹤0.01% 2843
2025
Q4 		$2.14K Buy
784
+602
+331% +$1.39K ﹤0.01% 2950
2025
Q3 		$395 Sell
182
-362
-67% -$855 ﹤0.01% 3227
2025
Q2 		$936 Sell
544
-5,035
-90% -$12.5K ﹤0.01% 3035
2025
Q1 		$18.6K Sell
5,579
-2,648
-32% -$13.7K ﹤0.01% 2097
2024
Q4 		$60.9K Sell
8,227
-471
-5% -$4.37K ﹤0.01% 1476
2024
Q3 		$81.7K Sell
8,698
-522
-6% -$4.95K ﹤0.01% 1319
2024
Q2 		$73.9K Sell
9,220
-159
-2% -$1.7K ﹤0.01% 1313
2024
Q1 		$139K Buy
9,379
+656
+8% +$7.63K ﹤0.01% 1015
2023
Q4 		$70.9K Buy
8,723
+6,277
+257% +$32.8K ﹤0.01% 1299
2023
Q3 		$11.1K Buy
2,446
+1,479
+153% +$9.66K ﹤0.01% 2152
2023
Q2 		$6.81K Buy
967
+681
+238% +$4.87K ﹤0.01% 2408
2023
Q1 		$1.75K Buy
+286
New +$1.97K ﹤0.01% 2841
2022
Q3 		– Sell
-51
Closed -$1K – 3215
2022
Q2 		$1K Sell
51
-796
-94% -$10.4K ﹤0.01% 2932
2022
Q1 		$14K Buy
847
+227
+37% +$3.51K ﹤0.01% 2002
2021
Q4 		$12K Buy
620
+31
+5% +$683 ﹤0.01% 2028
2021
Q3 		$15K Buy
589
+273
+86% +$6.43K ﹤0.01% 1881
2021
Q2 		$8K Buy
316
+193
+157% +$5.02K ﹤0.01% 2088
2021
Q1 		$4K Buy
+123
New +$5.1K ﹤0.01% 2245
2020
Q3 		– Sell
-49
Closed -$1K – 2672
2020
Q2 		$1K Buy
+49
New +$1.61K ﹤0.01% 2320

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

SignatureFD's IOVA Position: Q2 2026 in Review

SignatureFD held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 1,172 shares worth $4.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2870.

SignatureFD first reported a position in IOVA in Q2 2020 and has held it in 21 quarters since. The position peaked at $139K in Q1 2024. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • SignatureFD held 1,172 shares of Iovance Biotherapeutics worth $4.88K as of Q2 2026.
  • SignatureFD left its Iovance Biotherapeutics share count unchanged in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2870 holding.
  • SignatureFD first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 21 quarters since.
  • SignatureFD's Iovance Biotherapeutics position peaked at $139K in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.